Arcturus Therapeutics News

Arcturus Therapeutics | 8-K: Current report

Apr 5 17:04 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.2%)

Apr 5 12:25 ET

Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad

Mar 27 16:20 ET

Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad

Mar 21 17:32 ET

Arcturus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 19 16:43 ET

Arcturus Therapeutics | 8-K: Current report

Mar 19 06:06 ET

Arcturus Therapeutics | 10-K: Annual report

Mar 14 09:14 ET

Arcturus Therapeutics | 8-K/A: Current report (Amendment)

Mar 14 09:09 ET

Arcturus Therapeutics | 8-K: Current report

Mar 7 16:13 ET

Arcturus Therapeutics | 8-K: Current report

Feb 23 16:11 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.46%)

Feb 13 17:08 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nikko Asset Management Americas, Inc.(4.94%)

Feb 12 18:11 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”)(4.94%),Nikko Asset Management Co., Ltd. (“NAM”)(4.94%)

Feb 5 06:12 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(7.66%)

Jan 29 16:05 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.0%)

Jan 25 14:13 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.10%)

Jan 25 07:49 ET

Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Federated Hermes, Inc.(17.63%),Voting Shares Irrevocable Trust(17.63%), etc.

Jan 17 00:00 ET

Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer SASSINE ANDY

Dec 19, 2023 20:01 ET

Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad

Dec 19, 2023 20:01 ET

Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Kurata Lance

Dec 19, 2023 20:01 ET